A Study of Emapalumab for Pediatric Aplastic Anemia
Public ClinicalTrials.gov record NCT06430788. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Study identification
- NCT ID
- NCT06430788
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Interventions
- Emapalumab Biological
Biological
Eligibility (public fields only)
- Age range
- 0 Years to 25 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2024
- Primary completion
- May 20, 2029
- Completion
- May 20, 2029
- Last update posted
- Dec 16, 2025
2024 – 2029
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Recruiting |
| Cincinnati Children's Hospital Medical Center (Data collection only) | Cincinnati | Ohio | 45229 | Recruiting |
| Children's Hospital of Philadelphia (Data Collection AND Specimen Analysis) | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Virginia Commonwealth University (Data Collection Only ) | Richmond | Virginia | 23219 | Recruiting |
| Children's Hospital of Wisconsin (Data Collection Only) | Milwaukee | Wisconsin | 53226 | Recruiting |
| Medical College of Wisconsin (Data Collection AND Data Analysis) | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06430788, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06430788 live on ClinicalTrials.gov.